Over View
1.Introduction and Prospect of HBD Activities
1)Introduction
2)Prospect of HBD Activities and Expectations for Future
〜 Academia's View
3)Prospect of HBD Activities and Expectations for Future
〜 Industry's View
4)Prospect of HBD Activities and Expectations for Future
〜Regulator’s View
2.BRS
1)Evidences Reviewed in the Approval of BRS
〜 Absorb IIII
2)Evidences Reviewed in the Approval of BRS
〜 Absorb Japan
3)Evidences Reviewed in the Approval of BRS
〜 FDA Panel Recommendations
4)Remaining Concerns 〜 USA’s Concern
5)Remaining Concerns 〜 PMDA’s Concern
6)Expansion of Indication for a Newly Approved Device
3.FFRCT
1)Appropriate PCI 〜 Opinion from Academia
2)Appropriate PCI 〜 Regulatory Concern
3)Evidences Reviewed in the Approval of CT FFR
〜 Clinical Trial
4)What is the Best Way to Introduce CT-FFR
in Daily Practice? 〜 Regulatory Opinion
5)What is the Best Way to Introduce CT-FFR
in Daily Practice?〜 Opinion from Industry
4.Prevention from Bleeding
1)Key Lecture:Significance of Bleeding Complication
2)New Type of DES Proposed for Preventing Bleeding
〜 Proposal from Industry (1)
3)New Type of DES Proposed for Preventing Bleeding
〜Proposal from Industry(2)
4)Subset of the Patients Who Are at High Risk of Bleeding
〜Opinion from Industry
5)Subset of the Patients Who Are at High Risk of Bleeding
〜Opinion from Academia
6)Subset of the Patients Who Are at High Risk of Bleeding
〜Opinion from PMDA